Anticorps Recombinant de lapin anti-BCDIN3D

BCDIN3D Recombinant Antibody for WB, Cytometric bead array, Indirect ELISA

Hôte / Isotype

Lapin / IgG

Réactivité testée

Humain

Applications

WB, Cytometric bead array, Indirect ELISA

Conjugaison

Non conjugué

CloneNo.

240152A9

N° de cat : 83309-1-PBS

Synonymes

240152A9, BCDIN3 domain-containing protein, EC:2.1.1.-, RNA 5'-monophosphate methyltransferase



Informations sur le produit

83309-1-PBS cible BCDIN3D dans les applications de WB, Cytometric bead array, Indirect ELISA et montre une réactivité avec des échantillons Humain

Réactivité Humain
Hôte / Isotype Lapin / IgG
Clonalité Recombinant
Type Anticorps
Immunogène BCDIN3D Protéine recombinante Ag15613
Nom complet BCDIN3 domain containing
Masse moléculaire calculée 292 aa, 33 kDa
Poids moléculaire observé33 kDa
Numéro d’acquisition GenBankBC053560
Symbole du gène BCDIN3D
Identification du gène (NCBI) 144233
Conjugaison Non conjugué
Forme Liquide
Méthode de purification Purification par protéine A
Tampon de stockage PBS only
Conditions de stockageStore at -80°C. 20ul contiennent 0,1% de BSA.

Informations générales

BCDIN3D (BCDIN3 domain containing RNA methyltransferase), it is expected to be located in cytoplasm, which is ubiquitous expressed in prostate, lymph node and skeletal muscle. This gene encodes an RNA methyltransferase which belongs to the rossmann fold methyltransferase family and serves as a 5'-methylphosphate capping enzyme that is specific for cytoplasmic histidyl tRNA. The encoded protein contains an S-adenosylmethionine binding domain and uses the methyl group donor, S-adenosylmethionine. This gene is overexpressed in breast cancer cells, and is related to the tumorigenic phenotype and poor prognosis of breast cancer. The encoded protein is thought to promote the cellular invasion of breast cancer cells, by downregulating the expression of tumor suppressor miRNAs through the dimethylation of the 5-monophosphate of the corresponding precursor miRNAs. The molecular weight of BCDIN3D is 33 kDa.

{{ptg:RelatedPrimaryAntibodies}}